Crescita Therapeutics Inc.
CTX.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.26M | 6.26M | 5.96M | 6.00M | 5.94M |
| Total Receivables | 1.83M | 1.54M | 1.37M | 1.66M | 1.09M |
| Inventory | 3.00M | 3.44M | 3.85M | 3.62M | 3.55M |
| Prepaid Expenses | -- | 221.00K | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 265.70K | -- | 289.30K | 288.90K | 239.30K |
| Total Current Assets | 11.35M | 11.46M | 11.48M | 11.57M | 10.82M |
|
|
|||||
| Total Current Assets | 11.35M | 11.46M | 11.48M | 11.57M | 10.82M |
| Net Property, Plant & Equipment | 2.70M | 1.30M | 1.52M | 1.69M | 1.59M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 931.50K | 1.07M | 1.17M | 1.05M | 1.10M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 953.80K | 993.30K | 1.23M | 1.52M | 1.42M |
| Total Assets | 15.93M | 14.83M | 15.40M | 16.05M | 15.14M |
|
|
|||||
| Total Accounts Payable | 3.72M | 3.16M | 3.29M | 4.07M | 4.21M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 295.90K | 243.60K | 347.50K | 351.20K | 329.80K |
| Total Finance Division Other Current Liabilities | 35.90K | 36.50K | 35.90K | 36.70K | 34.80K |
| Total Other Current Liabilities | 35.90K | 36.50K | 35.90K | 36.70K | 34.80K |
| Total Current Liabilities | 4.05M | 3.44M | 3.68M | 4.46M | 4.57M |
|
|
|||||
| Total Current Liabilities | 4.05M | 3.44M | 3.68M | 4.46M | 4.57M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.50M | -- | -- | 90.20K | 169.80K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 25.90K | 24.10K | 56.70K | 55.00K | 49.40K |
| Total Liabilities | 5.57M | 3.47M | 3.73M | 4.60M | 4.79M |
|
|
|||||
| Common Stock & APIC | 43.02M | 43.69M | 43.00M | 43.99M | 41.77M |
| Retained Earnings | -33.47M | -33.14M | -32.11M | -33.35M | -32.20M |
| Treasury Stock & Other | 803.70K | 816.10K | 786.90K | 805.10K | 770.20K |
| Total Common Equity | 10.36M | 11.36M | 11.67M | 11.45M | 10.34M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.36M | 11.36M | 11.67M | 11.45M | 10.34M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 10.36M | 11.36M | 11.67M | 11.45M | 10.34M |
|
|
|||||